Vertex Pharmaceuticals: 10 weeks into a sell signal, but the decline stalls

Vertex Pharmaceuticals is in week 10 of a sell signal, but the last 3 weeks closed sideways: the decline has not confirmed. The technical picture over the 4 monitored weeks shows a progressive shift toward exhaustion of downside pressure. The quality band keeps trading not recommended, with the stock still 11.9% above its 200-week moving average.